Last week’s completion of a $200 million deal with NPE Malikie Innovations Limited saw more valuable IP leave Canadian ownership and was for a much lower amount than CEO John Chen and his board had originally planned for
As we reveal the agenda for IAM Live: Patent Transactions 2023, we asked patent dealmakers to tell their stories of relationship-building at IP conferences
The Canadian licensing company’s stark Q1 revenue decline to C$5.7 million stems from its enormous success in closing Apple and Kyocera patent licences last year
Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.
05 January 2022
Predictions from the IAM editorial team on what the next twelve months have in store
03 January 2022
“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call
22 December 2021
The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced
20 December 2021
Sizeable damage award against top white goods maker Gree vindicates smaller rival’s strategy for playing IP catch-up through transactions
14 December 2021
Court documents show that ZTE has filed a patent suit against Tinno Mobile, the Shenzhen-based company that owns French smartphone brand Wiko
08 December 2021
From the need for clarity to the problems of self-certification, top practitioners give their prescriptions for making the most of the pool model
07 December 2021
The automaker and its affiliates are growing their portfolios in technologies that will be critical for developing the car of the future
06 December 2021
Arbutus Biopharma’s shares soar in anticipation of mRNA jab royalty lawsuit after Federal Circuit ruling
03 December 2021
The deal shows how privacy and silo barriers to the commercialisation of information are being overcome
29 November 2021
Unlock unlimited access to all IAM content
